Table 2.
Case | Type of CCA | GA at first exam (weeks) | Fetal MRI score | Age at neurodev testing (years) | Neurodev outcome score* | Notes | ||
---|---|---|---|---|---|---|---|---|
Cognitive | Motor | Language | ||||||
1 | Partial (small body remnant) | 21 + 1 | 1 | 1.7 | 1 | 1 | 1 | |
2 | Partial (hypoplastic and dysplastic) + IH cyst | 22 + 1 | 3 | 4.2 | 1 | 2 | 1 | DISP1 heterozygote |
3 | Complete | 31 + 2 | 4 | 0.8 | 1 | 1 | 2 | |
4 | Complete | 24 + 3 | 2 | 2.9 | 1 | 0 | 2 | |
5 | Partial (small body remnant) | 23 + 3 | 3 | 3.1 | 1 | 2 | 1 | |
6 | Partial (hypoplastic and dysplastic) | 24 + 2 | 0 | 1.5 | 1 | 1 | 1 | |
7 | Complete | 22 + 4 | 4 | 3.5 | 0 | 0 | 0 | |
8 | Partial (small body remnant) | 23 + 0 | 2 | 2.0 | 1 | 1 | 1 | DCC mutation |
9 | Partial (small body remnant) | 19 + 1 | 2 | 3.8 | 1 | 1 | 1 | |
10 | Partial + pericallosal lipoma | 35 + 4 | 6 | 2.8 | 0 | 1 | 0 | Negative WES |
11 | Partial (absent posterior body + splenium) | 23 + 0 | 3 | 2.3 | 1 | 2 | 1 | Negative WES |
12 | Complete + IH cyst | 29 + 2 | 2 | 5.8 | 2 | 1 | 2 | |
13 | Complete | 22 + 1 | 4 | 2.0 | 0 | 0 | 1 | Microdeletion Xq28 |
14 | Complete | 27 + 1 | 3 | 0.5 | 1 | 1 | 1 | |
15 | Complete | 21 + 4 | 2 | 0.6 | 1 | 1 | 2 | |
16 | Partial (small body remnant) | 23 + 0 | 4 | 2.2 | 0 | 0 | 0 | ARID1B mutation |
17 | Complete | 23 + 0 | 5 | 3.5 | 0 | 0 | 0 | Severe delay; negative WES |
18 | Complete | 21 + 4 | 2 | 0.6 | 1 | 1 | 2 | |
19 | Complete | 30 + 0 | 5 | 5.0 | 1 | 1 | 0 | |
20 | Complete | 31 + 0 | 3 | 1.4 | 1 | 1 | 1 | |
21 | Partial (hypoplasia) | 35 + 3 | 5 | 3.5 | 0 | 0 | 0 | Severe delay |
When more than one fetal MRI examination was performed, the first is presented.
Neurodev outcome score: 0, below average (development quotient (DQ) or global scale index (GSI) < 85); 1, average (DQ/GSI 85–115); 2, above average (DQ/GSI > 115).
GA, gestational age; IH, interhemispheric; WES, whole‐exome sequencing.